Indirect Hyperbilirubinemia, Neonatal
Indirect Hyperbilirubinemia, Neonatal
Explore linked clinical trials. Standard reference: MESH:M04809911 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Efficacy of Ursodeoxycholic Acid (UDCA) as Adjuvant Therapy to Phototherapy in the Management of Neonatal Indirect Hyperbilirubinemia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, G6PD deficiency, Hemic and Lymphatic Diseases, Hyperbilirubinemia, Neonatal, Indirect Hyperbilirubinemia, Neonatal, Infant, Newborn, Diseases, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, anemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, hyperbilirubinemia, inborn carbohydrate metabolic disorder, inborn errors of metabolism, metabolic disease | Recruiting | Not applicable | 2026-04-21 | NCT07110987 |